Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Hansen

Showing results (131-140 of 166) with videos related to

Pageof 17
Sort By:
Intensive Care Medicine|August 24, 2019
Patient's characteristics and outcomes in necrotising soft-tissue infections: results from a Scandinavian, multicentre, prospective cohort studyMartin Bruun Madsen, Steinar Skrede, Anders Perner, et al.
Danish Medical Journal|April 29, 2022
Prevalence and duration of anti-SARS-CoV-2 antibodies in healthcare workersCaroline Klint Johannesen, Gry St Martin, Maria Elisabeth Lendorf, et al.
Circulation|February 2, 2019
Five-Year Clinical and Echocardiographic Outcomes From the NOTION Randomized Clinical Trial in Patients at Lower Surgical RiskHans Gustav Hørsted Thyregod, Nikolaj Ihlemann, Troels Højsgaard Jørgensen, et al.
Open Forum Infectious Diseases|August 16, 2021
SARS-CoV-2 Natural Antibody Response Persists for at Least 12 Months in a Nationwide Study From the Faroe IslandsMaria Skaalum Petersen, Cecilie Bo Hansen, Marnar Fríheim Kristiansen, et al.
Frontiers in Immunology|December 25, 2024
Unraveling the impact of SARS-CoV-2 mutations on immunity: insights from innate immune recognition to antibody and T cell responsesRafael Bayarri-Olmos, Adrian Sutta, Anne Rosbjerg, et al.
Journal of Internal Medicine|April 6, 2023
SARS-CoV-2 antibody dynamics over time and risk factors associated with infection and long COVID-19 symptoms in large working environmentsCecilie Bo Hansen, Kristina Dvoncova, Laura Pérez-Alós, et al.
Microbiology Spectrum|September 22, 2023
Distinguishing SARS-CoV-2 infection and vaccine responses up to 18 months post-infection using nucleocapsid protein and receptor-binding domain antibodiesIda Jarlhelt, Laura Pérez-Alós, Rafael Bayarri-Olmos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 24, 2021
SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding DomainRafael Bayarri-Olmos, Manja Idorn, Anne Rosbjerg, et al.
Journal of the American College of Cardiology|September 1, 2024
Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW TrialRichard E Pratley, Katherine R Tuttle, Peter Rossing, et al.
The Journal of Clinical Investigation|July 15, 2021
Discriminatory plasma biomarkers predict specific clinical phenotypes of necrotizing soft-tissue infectionsLaura M Palma Medina, Eivind Rath, Sanjeevan Jahagirdar, et al.
Pageof 17

Showing results (131-140 of 166) with videos related to

Sort By:
Pageof 17
Intensive Care Medicine|August 24, 2019
Patient's characteristics and outcomes in necrotising soft-tissue infections: results from a Scandinavian, multicentre, prospective cohort studyMartin Bruun Madsen, Steinar Skrede, Anders Perner, et al.
Danish Medical Journal|April 29, 2022
Prevalence and duration of anti-SARS-CoV-2 antibodies in healthcare workersCaroline Klint Johannesen, Gry St Martin, Maria Elisabeth Lendorf, et al.
Circulation|February 2, 2019
Five-Year Clinical and Echocardiographic Outcomes From the NOTION Randomized Clinical Trial in Patients at Lower Surgical RiskHans Gustav Hørsted Thyregod, Nikolaj Ihlemann, Troels Højsgaard Jørgensen, et al.
Open Forum Infectious Diseases|August 16, 2021
SARS-CoV-2 Natural Antibody Response Persists for at Least 12 Months in a Nationwide Study From the Faroe IslandsMaria Skaalum Petersen, Cecilie Bo Hansen, Marnar Fríheim Kristiansen, et al.
Frontiers in Immunology|December 25, 2024
Unraveling the impact of SARS-CoV-2 mutations on immunity: insights from innate immune recognition to antibody and T cell responsesRafael Bayarri-Olmos, Adrian Sutta, Anne Rosbjerg, et al.
Journal of Internal Medicine|April 6, 2023
SARS-CoV-2 antibody dynamics over time and risk factors associated with infection and long COVID-19 symptoms in large working environmentsCecilie Bo Hansen, Kristina Dvoncova, Laura Pérez-Alós, et al.
Microbiology Spectrum|September 22, 2023
Distinguishing SARS-CoV-2 infection and vaccine responses up to 18 months post-infection using nucleocapsid protein and receptor-binding domain antibodiesIda Jarlhelt, Laura Pérez-Alós, Rafael Bayarri-Olmos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 24, 2021
SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding DomainRafael Bayarri-Olmos, Manja Idorn, Anne Rosbjerg, et al.
Journal of the American College of Cardiology|September 1, 2024
Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW TrialRichard E Pratley, Katherine R Tuttle, Peter Rossing, et al.
The Journal of Clinical Investigation|July 15, 2021
Discriminatory plasma biomarkers predict specific clinical phenotypes of necrotizing soft-tissue infectionsLaura M Palma Medina, Eivind Rath, Sanjeevan Jahagirdar, et al.
Pageof 17